2011 annual financial data
Halozyme Therapeutics 2011 Financial results
Direct answer
Revenue was 56,086,436 USD.
Operating income was -19,838,941 USD and net income was -19,769,851 USD.
Operating cash flow was -34,350,425 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 56,086,436 USD
- Operating income
- -19,838,941 USD
- Net income
- -19,769,851 USD
- Operating cash flow
- -34,350,425 USD
Explore related company data
View all 2011 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Halozyme Therapeutics financial years